Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Neurofibromatosis type 2 with mild Pierre-Robin sequence showing a heterozygous chromosome 22q12 microdeletion
Sonoko Saito1, Noriko Ono1, Takashi Sasaki1,2
1Department of Dermatology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Abstract:
Pierre-Robin sequence (PRS) is a rare, congenital defect presenting with micrognathia, glossoptosis, and airway obstruction with variable inclusion of a cleft palate. Overlapping PRS with neurofibromatosis type 2 (NF2) is a syndrome caused by a chromosome 22q12 microdeletion including NF2. We describe a patient with severe early-onset NF2 overlapping with PRS that showed micrognathia, glossoptosis, and a mild form of cleft palate. We detected a de novo chromosome 22q12 microdeletion including MN1 and NF2 in the patient. Previous cases of overlapping PRS and NF2 caused by the chromosome 22q12 microdeletions showed severe NF2 phenotypes with variable severity of cleft palate and microdeletions of varying sizes. Genotype-phenotype correlations and comparison of the size and breakpoint of microdeletions suggest that some modifier genes distal to MN1 and NF2 might be linked to the cleft palate severity.
Insights
Pierre-Robin sequence (PRS) and neurofibromatosis type 2 (NF2) can overlap due to chromosome 22q12 microdeletions. This study identifies a novel microdeletion linking PRS and severe NF2, suggesting modifier genes influence PRS severity.
Area of Science:
- Genetics
- Developmental Biology
- Medical Genetics
Background:
- Pierre-Robin sequence (PRS) is a congenital condition characterized by micrognathia, glossoptosis, and airway obstruction, often with a cleft palate.
- Neurofibromatosis type 2 (NF2) is a genetic disorder typically causing tumors in the nervous system.
- Overlapping PRS and NF2 can result from chromosome 22q12 microdeletions encompassing the NF2 gene.
Observation:
- A patient presented with severe early-onset NF2 and PRS, including micrognathia, glossoptosis, and a mild cleft palate.
- Genetic analysis revealed a de novo chromosome 22q12 microdeletion in the patient, including the MN1 and NF2 genes.
Findings:
- The identified microdeletion in this patient is distinct from previously reported cases of overlapping PRS and NF2.
- Comparison of this case with prior literature suggests that the size and breakpoints of 22q12 microdeletions may correlate with PRS severity.
- Modifier genes located distal to MN1 and NF2 might play a role in the variable expressivity of cleft palate in this syndrome.
Implications:
- This case expands the understanding of genotype-phenotype correlations in chromosome 22q12 microdeletion syndromes.
- Identifying modifier genes could lead to improved prediction of PRS severity and personalized management strategies.
- Further research into the genetic architecture of 22q12 microdeletions is warranted for a comprehensive understanding of PRS and NF2 overlap.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Neurulation
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Abnormal Proliferation
Neural Regulation